Loading…
Protection against malaria induced by chirally modified Plasmodium falciparum’s MSP-1 42 pseudopeptides
The C-terminal portion of the Plasmodium falciparum blood stage MSP-1 antigen plays a key role in invasion of human erythrocytes. The MSP-1 1282–1301 non-polymorphic 1585 peptide, from the processed MSP-1 42 fragment, is poorly immunogenic and highly α-helical [Angew. Chem. Int. Ed. 40 (2001) 4654]....
Saved in:
Published in: | Biochemical and biophysical research communications 2005-04, Vol.329 (3), p.1053-1066 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The C-terminal portion of the
Plasmodium falciparum blood stage MSP-1 antigen plays a key role in invasion of human erythrocytes. The MSP-1
1282–1301 non-polymorphic 1585 peptide, from the processed MSP-1
42 fragment, is poorly immunogenic and highly α-helical [Angew. Chem. Int. Ed. 40 (2001) 4654]. Assessing the α-carbon asymmetry and its implication in the host immune response is proposed in this work to overcome the 1585 peptide’s immunological properties. Accordingly, the effect of incorporating single
d-amino acids and ψ-[CH
2–NH] isoster bonds into the 1585 peptide was examined both at the immunogenic and 3D-structure levels. Therefore, specific binding to RBCs is promoted by site-directed chiral modifications on the native peptide as well as by simultaneously combining specific
d-substitutions with ψ-[CH
2–NH] isoster bonds transforming this molecule into a high specific HLAβ1*1101 allele binder.
d-analog pseudopeptide immunized animals induced antibodies selectively recognizing a recombinant as well as native MSP-1
42 and MSP-1
33 fragments. Protection and low parasitemia levels were induced in
Aotus monkeys immunized with the EVLYL(
dK)PLAGVYRSLKKQLE analog. Peptide α-carbon chiral transformation is therefore an important target for structural modulation and, consequently, represents a novel approach towards designing multi-component subunit-based malarial vaccines. |
---|---|
ISSN: | 0006-291X 1090-2104 |
DOI: | 10.1016/j.bbrc.2005.01.165 |